阿摩線上測驗 登入

試題詳解

試卷:105年 - 105 台灣疼痛醫學會專科醫師考題#122415 | 科目:台灣疼痛醫學會專科醫師

試卷資訊

試卷名稱:105年 - 105 台灣疼痛醫學會專科醫師考題#122415

年份:105年

科目:台灣疼痛醫學會專科醫師

29. Which of the following is the acceptable statement about pathogenesis of FMS?
(A) There is evidence to suggest that FMS is a disorder of abnormal processing of sensory information within the central nervous system.
(B) Several neurochemical mediators of pain, substance P, nerve growth factor, dynorphin A, glutamate, nitric oxide, serotonin and noradrenaline are viewed as pronociceptive because they carry or amplify afferent signals, leading to the brain perception of increased pain.
(C) The elevation of cerebrospinal fluid substance P in FMS is due to lowered activity of cerebrospinal fluid substance P esterase because the rate of cleavage of libeled substance P by FMS cerebrospinal fluid was lower than normal.
(D) In different subtypes of FMS, it is believed that nerve growth factor may be responsible for the elevated cerebrospinal fluid substance P through its effects on central sensitization and neuroplasticity.
(E) A specific Gi-protein–coupled receptor in peripheral blood leukocytes was found to be dysfunctional in patients with FMS. This resulted in lower baseline, also depressed intracellular levels of cyclic AMP and proposed as a diagnostic test for FMS.
正確答案:登入後查看

詳解 (共 1 筆)

推薦的詳解#6890753
未解鎖
1. 題目解析 這道考題詢問的是關於纖...
(共 764 字,隱藏中)
前往觀看
0
0